Sept. 13, 2022– President Biden’s call for a “moonshot” campaign to cut the death rate from cancer by at least 50% over the next 25 years focuses renewed attention on ensuring access to affordable cancer care for patients living with low incomes and those who live in often-underserved rural communities across the country. The 340B drug pricing program plays a vital role in … [Read more...]
340B Is a Key Element of the Mission Against Breast Cancer
Oct. 22, 2021– Each October, national organizations aim to make more Americans aware of what they can do to prevent and treat breast cancer as well as support people whose lives have been affected by the disease. Breast Cancer Awareness Month also is a time to look at how the 340B drug pricing program can help expand prevention and treatment efforts. Screenings Are … [Read more...]
340B Is a Cancer Lifeline for the Underserved
June 25, 2020— Although cancer can sicken and kill people of all races and ethnicities, disability statuses, and socioeconomic levels, it is a documented fact that members of certain underserved populations are more likely to have problems accessing cancer treatments and to have worse health outcomes. It is also a documented fact that hospitals participating in the 340B … [Read more...]
MedPAC Report Addresses Key 340B Questions
March 18, 2020– A new report from a respected, independent congressional advisory panel sheds light on several of the key questions surrounding the 340B drug pricing program. In its March 2020 report to Congress, the Medicare Payment Advisory Commission (MedPAC) examined whether participation in the 340B program leads to higher drug spending for Medicare patients with five … [Read more...]
The 340B Proof of Concept: Better Patient Health
December 5, 2019– When policymakers assess whether programs they created are having positive impacts on people and communities, they ask for evidence that things are better than they were before the program took effect. When it comes to the 340B drug pricing program, that proof is in the improved health of patients. A new report by 340B Health has important information about … [Read more...]
Faces of 340B: Meeting Regional Health Challenges
September 19, 2019— Jefferson County in southeast Arkansas has its share of health problems that include higher-than-average rates of diabetes, cancer, and heart disease. But this predominantly rural community faces additional challenges that stem from the socioeconomic status of its residents – challenges that the region’s safety-net hospital tackles with the help of the 340B … [Read more...]
New Study on Cancer Care Has Important Implications for 340B
August 7, 2018—Critics of the 340B drug pricing program often claim that the lower cost of drugs for 340B hospitals is driving up the cost of care for cancer patients in hospital outpatient departments. But a new study published in the American Journal of Managed Care (AJMC) shows cancer care spending is actually lower in hospitals when adjusted for the severity of patients’ … [Read more...]